Podocyte ACE2 protects against diabetic nephropathy
- PMID: 22791320
- PMCID: PMC7112297
- DOI: 10.1038/ki.2012.127
Podocyte ACE2 protects against diabetic nephropathy
Abstract
As new components of the renin-angiotensin system (RAS) are elucidated, our understanding of the complexities of their interactions also advances. Previous studies have determined that podocytes possess a local RAS that can generate angiotensin II. Podocytes have also been shown to express angiotensin-converting enzyme 2 (ACE2), which can decrease angiotensin II levels by generation of angiotensin-(1-7). Nadarajah et al. now show that increased podocyte ACE2 activity can attenuate the development of diabetic nephropathy.
Figures
Comment on
-
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice.Kidney Int. 2012 Aug;82(3):292-303. doi: 10.1038/ki.2012.83. Epub 2012 Apr 4. Kidney Int. 2012. PMID: 22475818 Free PMC article.
References
-
- Gurley S.B., Coffman T.M. Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages. Exp Physiol. 2008;93:538–542. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
